Related Experiment Video

Updated: May 25, 2026

Atomic Scale Structural Studies of Macromolecular Assemblies by Solid-state Nuclear Magnetic Resonance Spectroscopy
14:55

Atomic Scale Structural Studies of Macromolecular Assemblies by Solid-state Nuclear Magnetic Resonance Spectroscopy

Published on: September 17, 2017

Toxic prefibrillar α-synuclein amyloid oligomers adopt a distinctive antiparallel β-sheet structure

María Soledad Celej1, Rabia Sarroukh, Erik Goormaghtigh

  • 1Centro de Investigaciones en Química Biológica de Córdoba (CIQUIBIC, UNC-CONICET), Departamento de Química Biológica, Facultad de Ciencias Químicas, Universidad Nacional de Córdoba, Haya de la Torre y Medina Allende, Ciudad Universitaria, X5000HUA Córdoba, Argentina. mcelej@mail.fcq.unc.edu.ar

The Biochemical Journal
|February 10, 2012
PubMed

Insights

Researchers studied alpha-synuclein (AS) in Parkinson's disease. They found that AS oligomers have an antiparallel beta-sheet structure, while fibrils have a parallel arrangement, offering insights into disease mechanisms.

Area of Science:

  • Neuroscience
  • Biochemistry
  • Structural Biology

Background:

  • Parkinson's disease (PD) is a neurodegenerative disorder linked to amyloid deposits of alpha-synuclein (AS) in the brain.
  • Cytotoxicity in PD is attributed to soluble AS prefibrillar species, but their mechanisms remain unclear.
  • Understanding the structure of AS oligomers and fibrils is crucial for elucidating AS aggregation and toxicity.

Purpose of the Study:

  • To investigate the structural differences in beta-sheet organization between soluble AS oligomers and insoluble AS fibrils.
  • To gain deeper insights into the molecular mechanisms underlying AS-induced cytotoxicity in Parkinson's disease.

Main Methods:

  • Utilized attenuated total reflection-Fourier-transform infrared (ATR-FTIR) spectroscopy, a technique sensitive to beta-sheet structures.
  • Analyzed spectral data to determine the specific beta-sheet arrangements within AS oligomers and fibrils.

Main Results:

  • AS oligomers were found to adopt an antiparallel beta-sheet structure.
  • AS fibrils were characterized by a parallel beta-sheet arrangement.
  • Distinct structural conformations were identified between oligomeric and fibrillar forms of AS.

Conclusions:

  • The study reveals distinct beta-sheet organizations in AS oligomers (antiparallel) versus fibrils (parallel).
  • These conformational differences likely play a role in the early stages of AS aggregation and contribute to the pathogenicity of AS oligomers in Parkinson's disease.
  • Structural insights advance the understanding of AS aggregation pathways and neurotoxicity mechanisms.

More Related Videos

Rapid Generation of Amyloid from Native Proteins In vitro05:48

Rapid Generation of Amyloid from Native Proteins In vitro

Published on: December 5, 2013

A11-positive β-amyloid Oligomer Preparation and Assessment Using Dot Blotting Analysis06:17

A11-positive β-amyloid Oligomer Preparation and Assessment Using Dot Blotting Analysis

Published on: May 22, 2018

Related Concept Videos

Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Protein and Protein Structure02:15

Protein and Protein Structure

Proteins are one of the most abundant organic molecules in living systems and have the most diverse range of functions of all macromolecules. Proteins may be structural, regulatory, contractile, or protective. They may serve in transport, storage, or membranes; or they may be toxins or enzymes. Their structures, like their functions, vary greatly. They are all, however, amino acid polymers arranged in a linear sequence.
A protein's shape is critical to its function. For example, an enzyme can...
Protein Folding01:22

Protein Folding

Overview
Protein Folding01:25

Protein Folding

Proteins are chains of amino acids linked together by peptide bonds. Upon synthesis, a protein folds into a three-dimensional conformation, critical to its biological function. Interactions between its constituent amino acids guide protein folding, and hence the protein structure is primarily dependent on its amino acid sequence.
Protein Structure Is Critical to Its Biological Function
Proteins perform a wide range of biological functions such as catalyzing chemical reactions, providing...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...